
[ Thu, Sep 23rd 2021 ]: WOPRAI

[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI

[ Tue, Sep 21st 2021 ]: WOPRAI
Nathan Weinstein Maintained (CDTX) at Strong Buy with Decreased Target to $160 on, Sep 22nd, 2021


🞛 This publication is a summary or evaluation of another publication
Nathan Weinstein of Aegis Capital, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $180 to $160 on, Sep 22nd, 2021.
Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30